
They test reconstruction techniques, non-uniform attenuation
and scatter correction methods using different radionuclides
under realistic conditions
The Heart/Thorax Phantom is ideal for evaluation of
detectability, extent and severity of myocardial infarcts in
patients. This Phantom also provides valid assessment of
mammoscintigraphy techniques. The Striatal Phantom optimizes
quantitative imaging in patients, using PET or SPECT.

Hendel RC, Berman DS, Cullom SJ et al: Multicenter clinical
trial to evaluate the efficacy of correction for photon
attenuation and scatter in SPECT myocardial perfusion imaging.
Circulation 99:2742-2749, 1999.
Doshi NK, Basic M and Cherry S: Evaluation of the
detectability of breast cancer lesions using a modified
anthropomorphic phantom. J. Nucl. Med. 1998, 39: 1951-1957.
Stodilka RZ, Kemp BJ, Prato FS et al.: Importance of bone
attenuation in brain SPECT quantification. J. Nucl. Med. 1998,
39: 190-197.
Stodilka RZ, Kemp BJ, Peter Msaki et al: The relative
contributions of scatter and attenuation corrections toward
improved brain SPECT quantification. Phys. Med. Biol. 1998,
43: 2991-3008.
Leong LK, O’Connor MK and Maraganore DM: Quantification of
Iodine-123-beta-CIT dopamine receptor uptake in a phantom
model. J. Nucl. Med. Technol 1999, 27:117-122
Kuikka JT, Yant J, Jurhu J et al: Imaging the structure of the
striatum: a fractal approach to SPECT image interpretation.
Physiol. Meas. 19:367-374, 1998.
Nuclear Medicine orders are handled exclusively by Capintec.
For International:
Capintec
6 Arrow Road
Ramsey, NJ 07446
Ph: 201-825-9500
Fx: 201-825-4829
Email: reve@capintec.com
For Domestic: the address is;
Capintec
620 Alpha Drive
Pittsburgh, PA 15238
Ph: 412-963-1988
Fx: 412-936-0610
email:
ERytel@capintec.com
back to top
|